4
Changes in Ownership
LEXICON PHARMACEUTICALS, INC. Filed Acc 0001127602-22-007175
VP, Chief Commercial Officer gave up 8,261 shares (to pay taxes)
- VP, Chief Commercial Officer acquired 30,128 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Seth Kiernan · VP, Chief Commercial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-28 | Exercise or conversion : show line 1 in the form | +10,007 | 10,007 | D | ||
| 2022-02-28 | Exercise or conversion : show line 2 in the form | +14,834 | 24,841 | D | ||
| 2022-02-28 | Exercise or conversion : show line 3 in the form | +5,287 | 30,128 | D | ||
| 2022-02-28 | Shares withheld for taxes : show line 4 in the form | −8,261 | $2.85 | $23,544 | 21,867 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-28 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −10,007 | 0 | D |
| 2022-02-28 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −14,834 | 14,833 | D |
| 2022-02-28 | Exercise or conversion : show line 7 in the form Restricted Stock Units | −5,287 | 10,573 | D |
Loading xslF345X03/form4.xml…